ATZORI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 1.923
EU - Europa 217
AS - Asia 42
SA - Sud America 1
Totale 2.183
Nazione #
US - Stati Uniti d'America 1.921
IT - Italia 41
SE - Svezia 29
IE - Irlanda 28
CN - Cina 25
UA - Ucraina 24
FR - Francia 19
DE - Germania 18
NL - Olanda 16
GB - Regno Unito 15
SG - Singapore 13
PL - Polonia 10
RU - Federazione Russa 9
FI - Finlandia 4
AT - Austria 2
CA - Canada 2
KR - Corea 2
CL - Cile 1
CZ - Repubblica Ceca 1
MD - Moldavia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 2.183
Città #
Wilmington 501
Houston 491
Woodbridge 470
Fairfield 93
Chandler 65
Ashburn 61
Ann Arbor 30
Seattle 30
Cambridge 25
Rome 24
Dublin 22
New York 20
Medford 14
Dearborn 13
Beijing 10
Kraków 10
Jacksonville 9
Singapore 8
Lawrence 7
Zhengzhou 7
Center 5
Palo Alto 5
Boardman 4
London 4
Moscow 4
Shanghai 4
Guidonia Montecelio 3
Washington 3
Civitavecchia 2
Cremona 2
Del Norte 2
Dongguan 2
Hefei 2
Munich 2
Mülheim 2
Naples 2
Phoenix 2
San Diego 2
Scottsdale 2
Vienna 2
Acton 1
Brno 1
Calgary 1
Carrara 1
Chisinau 1
Council Bluffs 1
Dong Ket 1
Genoa 1
Helsinki 1
Hounslow 1
Islington 1
Los Gatos 1
Milan 1
Saint Petersburg 1
Salt Lake City 1
San Mateo 1
Seoul 1
Stockholm 1
Taipei 1
Toronto 1
Wernigerode 1
Totale 1.987
Nome #
Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth 407
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding 346
Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding 341
Poly(ADP‑ribose) polymerase inhibitor olaparib hampers placental growth factor‑driven activation of myelomonocytic cells. 305
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. 298
Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1. 283
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib 170
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor 27
Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential 18
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose 18
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors 14
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research 8
Totale 2.235
Categoria #
all - tutte 5.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.185


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020564 0 49 43 53 51 61 63 59 65 53 32 35
2020/2021389 36 39 38 72 30 31 34 46 11 29 19 4
2021/202278 4 8 11 3 0 4 4 4 8 8 10 14
2022/2023153 11 14 6 26 5 36 17 5 12 0 13 8
2023/2024103 7 3 5 5 12 32 7 1 4 6 14 7
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 2.235